The role of laboratory diagnostics in emerging viral infections: the example of the Middle East respiratory syndrome epidemic

Journal of Microbiology

Volumn 55, Issue 3, 2017, Pages 172-182

  Chan, Jasper F W ^a,b   Sridhar, Siddharth ^b   Yip, Cyril C Y ^b   Lau, Susanna K P ^a,b   Woo, Patrick C Y ^a,b  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

coronavirus; diagnosis; epidemic; MERS; middle east

Indexed keywords

COMMUNICABLE DISEASES, EMERGING; CORONAVIRIDAE; CORONAVIRUS INFECTIONS; DEVICES; EPIDEMIC; HUMAN; IMMUNOASSAY; ISOLATION AND PURIFICATION; LABORATORY TEST; MOLECULAR DIAGNOSIS; POLYMERASE CHAIN REACTION; PROCEDURES; SPECIMEN HANDLING; STANDARDS; VIROLOGY; VIRUS CULTURE;

CLINICAL LABORATORY TECHNIQUES; COMMUNICABLE DISEASES, EMERGING; CORONAVIRUS; CORONAVIRUS INFECTIONS; EPIDEMICS; HUMANS; IMMUNOASSAY; MOLECULAR DIAGNOSTIC TECHNIQUES; POLYMERASE CHAIN REACTION; SPECIMEN HANDLING; VIRUS CULTIVATION;

EID: 85013994770     PISSN: 12258873     EISSN: 19763794     Source Type: Journal    
DOI: 10.1007/s12275-017-7026-y     Document Type: Review

References (110)

1. Abd El Wahed, A., Patel, P., Heidenreich, D., Hufert, F.T., and Weidmann, M. 2013. Reverse transcription recombinase polymerase amplification assay for the detection of middle East respiratory syndrome coronavirus. PLoS Curr. 5, DOI: 10.1371/currents. outbreaks.62df1c7c75ffc96cd59034531e2e8364.
2. Abroug, F., Slim, A., Ouanes-Besbes, L., Hadj Kacem, M.A., Dachraoui, F., Ouanes, I., Lu, X., Tao, Y., Paden, C., Caidi, H., et al. 2014. Family cluster of Middle East respiratory syndrome coronavirus infections, Tunisia, 2013. Emerg. Infect. Dis. 20, 1527–1530.
3. Aburizaiza, A.S., Mattes, F.M., Azhar, E.I., Hassan, A.M., Memish, Z.A., Muth, D., Meyer, B., Lattwein, E., Muller, M.A., and Drosten, C. 2014. Investigation of anti-middle East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, fall 2012. J. Infect. Dis. 209, 243–246.
4. Agrawal, A.S., Garron, T., Tao, X., Peng, B.H., Wakamiya, M., Chan, T.S., Couch, R.B., and Tseng, C.T. 2015. Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease. J. Virol. 89, 3659–3670.
5. Alagaili, A.N., Briese, T., Mishra, N., Kapoor, V., Sameroff, S.C., Burbelo, P.D., de Wit, E., Munster, V.J., Hensley, L.E., Zalmout, I.S., et al. 2014. Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. MBio 5, e00884–00814.
6. Arabi, Y.M., Harthi, A., Hussein, J., Bouchama, A., Johani, S., Hajeer, A.H., Saeed, B.T., Wahbi, A., Saedy, A., AlDabbagh, T., et al. 2015. Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV). Infection 43, 495–501.
7. Assiri, A., Al-Tawfiq, J.A., Al-Rabeeah, A.A., Al-Rabiah, F.A., Al- Hajjar, S., Al-Barrak, A., Flemban, H., Al-Nassir, W.N., Balkhy, H.H., Al-Hakeem, R.F., et al. 2013a. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect. Dis. 13, 752–761.
8. Assiri, A., McGeer, A., Perl, T.M., Price, C.S., Al Rabeeah, A.A., Cummings, D.A., Alabdullatif, Z.N., Assad, M., Almulhim, A., Makhdoom, H., et al. 2013b. Hospital outbreak of Middle East respiratory syndrome coronavirus. N. Engl. J. Med. 369, 407–416.
9. Bhadra, S., Jiang, Y.S., Kumar, M.R., Johnson, R.F., Hensley, L.E., and Ellington, A.D. 2015. Real-time sequence-validated loop-mediated isothermal amplification assays for detection of Middle East respiratory syndrome coronavirus (MERS-CoV). PLoS One 10, e0123126.
10. Buchholz, U., Muller, M.A., Nitsche, A., Sanewski, A., Wevering, N., Bauer-Balci, T., Bonin, F., Drosten, C., Schweiger, B., Wolff, T., et al. 2013. Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012. Euro Surveill. 18, pii: 20406.
11. Chan, J.F., Chan, K.H., Choi, G.K., To, K.K., Tse, H., Cai, J.P., Yeung, M.L., Cheng, V.C., Chen, H., Che, X.Y., et al. 2013a. Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation. J. Infect. Dis. 207, 1743–1752.
12. Chan, J.F., Chan, K.H., Kao, R.Y., To, K.K., Zheng, B.J., Li, C.P., Li, P.T., Dai, J., Mok, F.K., Chen, H., et al. 2013b. Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus. J. Infect. 67, 606–616.
13. Chan, J.F., Choi, G.K., Tsang, A.K., Tee, K.M., Lam, H.Y., Yip, C.C., To, K.K., Cheng, V.C., Yeung, M.L., Lau, S.K., et al. 2015a. Development and evaluation of novel real-time reverse transcription-PCR assays with locked nucleic acid probes targeting leader sequences of human-pathogenic coronaviruses. J. Clin. Microbiol. 53, 2722–2726.
14. Chan, J.F., Choi, G.K., Yip, C.C., Cheng, V.C., and Yuen, K.Y. 2016. Zika fever and congenital Zika syndrome: An unexpected emerging arboviral disease. J. Infect. 72, 507–524.
15. Chan, J.F., Lau, S.K., To, K.K., Cheng, V.C., Woo, P.C., and Yuen, K.Y. 2015b. Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin. Microbiol. Rev. 28, 465–522.
16. Chan, J.F., Lau, S.K., and Woo, P.C. 2013c. The emerging novel Middle East respiratory syndrome coronavirus: the “knowns” and “unknowns”. J. Formos. Med. Assoc. 112, 372–381.
17. Chan, J.F., Li, K.S., To, K.K., Cheng, V.C., Chen, H., and Yuen, K.Y. 2012. Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic? J. Infect. 65, 477–489.
18. Chan, J.F., To, K.K., Chen, H., and Yuen, K.Y. 2015c. Cross-species transmission and emergence of novel viruses from birds. Curr. Opin. Virol. 10, 63–69.
19. Chan, J.F., To, K.K., Tse, H., Jin, D.Y., and Yuen, K.Y. 2013d. Interspecies transmission and emergence of novel viruses: lessons from bats and birds. Trends Microbiol. 21, 544–555.
20. Chan, J.F., Yao, Y., Yeung, M.L., Deng, W., Bao, L., Jia, L., Li, F., Xiao, C., Gao, H., Yu, P., et al. 2015d. Treatment with lopinavir/ ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset. J. Infect. Dis. 212, 1904–1913.
21. Chan, K.H., Chan, J.F., Tse, H., Chen, H., Lau, C.C., Cai, J.P., Tsang, A.K., Xiao, X., To, K.K., Lau, S.K., et al. 2013e. Cross-reactive antibodies in convalescent SARS patients’ sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests. J. Infect. 67, 130–140.
22. Chan, K.H., Maldeis, N., Pope, W., Yup, A., Ozinskas, A., Gill, J., Seto, W.H., Shortridge, K.F., and Peiris, J.S. 2002. Evaluation of the Directigen FluA+B test for rapid diagnosis of influenza virus type A and B infections. J. Clin. Microbiol. 40, 1675–1680.
23. Chan, K.H., Poon, L.L., Cheng, V.C., Guan, Y., Hung, I.F., Kong, J., Yam, L.Y., Seto, W.H., Yuen, K.Y., and Peiris, J.S. 2004. Detection of SARS coronavirus in patients with suspected SARS. Emerg. Infect. Dis. 10, 294–299.
24. Chan, R.W., Chan, M.C., Agnihothram, S., Chan, L.L., Kuok, D.I., Fong, J.H., Guan, Y., Poon, L.L., Baric, R.S., Nicholls, J.M., et al. 2013f. Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures. J. Virol. 87, 6604–6614.
25. Chen, Y., Chan, K.H., Hong, C., Kang, Y., Ge, S., Chen, H., Wong, E.Y., Joseph, S., Patteril, N.G., Wernery, U., et al. 2016. A highly specific rapid antigen detection assay for on-site diagnosis of MERS. J. Infect. 73, 82–84.
26. Chen, Y., Chan, K.H., Kang, Y., Chen, H., Luk, H.K., Poon, R.W., Chan, J.F., Yuen K.Y., Xia, N., Lau, S.K., et al. 2015. A sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus. Emerg. Microbes Infect. 4, e26.
27. Cho, S.Y., Kang, J.M., Ha, Y.E., Park, G.E., Lee, J.Y., Ko, J.H., Lee, J.Y., Kim, J.M., Kang, C.I., Jo, I.J., et al. 2016. MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study. Lancet 388, 994–1001.
28. Chu, H., Zhou, J., Wong, B.H., Li, C., Chan, J.F., Cheng, Z.S., Yang, D., Wang, D., Lee, A.C., Li, C., et al. 2016. Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. J. Infect. Dis. 213, 904–914.
29. Chu, H., Zhou, J., Wong, B.H., Li, C., Cheng, Z.S., Lin, X., Poon, V.K., Sun, T., Lau, C.C., Chan, J.F., et al. 2014. Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response. Virology 454-455, 197–205.
30. Coleman, C.M., Matthews, K.L., Goicochea, L., and Frieman, M.B. 2014. Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus. J. Gen. Virol. 95, 408–412.
31. Corman, V.M., Albarrak, A.M., Omrani, A.S., Albarrak, M.M., Farah, M.E., Almasri, M., Muth, D., Sieberg, A., Meyer, B., Assiri, A.M., et al. 2016. Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection. Clin. Infect. Dis. 62, 477–483.
32. Corman, V.M., Eckerle, I., Bleicker, T., Zaki, A., Landt, O., Eschbach- Bludau, M., van Boheemen, S., Gopal, R., Ballhause, M., Bestebroer, T.M., et al. 2012a. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill. 17, pii: 20285.
33. Corman, V.M., Muller, M.A., Costabel, U., Timm, J., Binger, T., Meyer, B., Kreher, P., Lattwein, E., Eschbach-Bludau, M., Nitsche, A., et al. 2012b. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill. 17, pii: 20334.
34. Corman, V.M., Olschlager, S., Wendtner, C.M., Drexler, J.F., Hess, M., and Drosten, C. 2014. Performance and clinical validation of the RealStar MERS-CoV kit for detection of Middle East respiratory syndrome coronavirus RNA. J. Clin. Virol. 60, 168–171.
35. de Wilde, A.H., Jochmans, D., Posthuma, C.C., Zevenhoven-Dobbe, J.C., van Nieuwkoop, S., Bestebroer, T.M., van den Hoogen, B.G., Neyts, J., and Snijder, E.J. 2014. Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture. Antimicrob. Agents Chemother. 58, 4875–4884.
36. de Wilde, A.H., Raj, V.S., Oudshoorn, D., Bestebroer, T.M., van Nieuwkoop, S., Limpens, R.W., Posthuma, C.C., van der Meer, Y., Barcena, M., Haagmans, B.L., et al. 2013. MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment. J. Gen. Virol. 94, 1749–1760.
37. de Wit, E., Prescott, J., Baseler, L., Bushmaker, T., Thomas, T., Lackemeyer, M.G., Martellaro, C., Milne-Price, S., Haddock, E., Haagmans, B.L., et al. 2013a. The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in Syrian hamsters. PLoS One 8, e69127.
38. de Wit, E., Rasmussen, A.L., Falzarano, D., Bushmaker, T., Feldmann, F., Brining, D.L., Fischer, E.R., Martellaro, C., Okumura, A., Chang, J., et al. 2013b. Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques. Proc. Natl. Acad. Sci. USA 110, 16598–16603.
39. Douglas, C.E., Kulesh, D.A., Jaissle, J.G., and Minogue, T.D. 2015. Real-time reverse transcriptase polymerase chain reaction assays for Middle East Respiratory Syndrome. Mol. Cell Probes 29, 511–513.
40. Drosten, C., Meyer, B., Muller, M.A., Corman, V.M., Al-Masri, M., Hossain, R., Madani, H., Sieberg, A., Bosch, B.J., Lattwein, E., et al. 2014. Transmission of MERS-coronavirus in household contacts. N. Engl. J. Med. 371, 828–835.
41. Drosten, C., Seilmaier, M., Corman, V.M., Hartmann, W., Scheible, G., Sack, S., Guggemos, W., Kallies, R., Muth, D., Junglen, S., et al. 2013. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect. Dis. 13, 745–751.
42. Dyall, J., Coleman, C.M., Hart, B.J., Venkataraman, T., Holbrook, M.R., Kindrachuk, J., Johnson, R.F., Olinger, G.G., Jahrling, P.B., Laidlaw, M., et al. 2014. Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrob. Agents Chemother. 58, 4885–4893.
43. Eckerle, I., Corman, V.M., Muller, M.A., Lenk, M., Ulrich, R.G., and Drosten, C. 2014. Replicative capacity of MERS coronavirus in livestock cell lines. Emerg. Infect. Dis. 20, 276–279.
44. Falzarano, D., de Wit, E., Feldmann, F., Rasmussen, A.L., Okumura, A., Peng, X., Thomas, M.J., van Doremalen, N., Haddock, E., Nagy, L., et al. 2014. Infection with MERS-CoV causes lethal pneumonia in the common marmoset. PLoS Pathog. 10, e1004250.
45. Gao, J., Lu, G., Qi, J., Li, Y., Wu, Y., Deng, Y., Geng, H., Li, H., Wang, Q., Xiao, H., et al. 2013. Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus. J. Virol. 87, 13134–13140.
46. Glushakova, L.G., Sharma, N., Hoshika, S., Bradley, A.C., Bradley, K.M., Yang, Z., and Benner, S.A. 2015. Detecting respiratory viral RNA using expanded genetic alphabets and self-avoiding DNA. Anal. Biochem. 489, 62–72.
47. Guan, M., Chen, H.Y., Tan, P.H., Shen, S., Goh, P.Y., Tan, Y.J., Pang, P.H., Lu, Y., Fong, P.Y., and Chin, D. 2004. Use of viral lysate antigen combined with recombinant protein in Western immunoblot assay as confirmatory test for serodiagnosis of severe acute respiratory syndrome. Clin. Diagn. Lab. Immunol. 11, 1148–1153.
48. Guery, B., Poissy, J., el Mansouf, L., Sejourne, C., Ettahar, N., Lemaire, X., Vuotto, F., Goffard, A., Behillil, S., Enouf, V., et al. 2013. Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. Lancet 381, 2265–2272.
49. Haagmans, B.L., Al Dhahiry, S.H., Reusken, C.B., Raj, V.S., Galiano, M., Myers, R., Godeke, G.J., Jonges, M., Farag, E., Diab, A., et al. 2014. Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect. Dis. 14, 140–145.
50. Haagmans, B.L., van den Brand, J.M., Provacia, L.B., Raj, V.S., Stittelaar, K.J., Getu, S., de Waal, L., Bestebroer, T.M., van Amerongen, G., Verjans, G.M., et al. 2015. Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits. J. Virol. 89, 6131–6135.
51. Jiang, L., Wang, N., Zuo, T., Shi, X., Poon, K.M., Wu, Y., Gao, F., Li, D., Wang, R., Guo, J., et al. 2014. Potent neutralization of MERSCoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein. Sci. Transl. Med. 6, 234ra259.
52. Kim, C.J., Choi, W.S., Jung, Y., Kiem, S., Seol, H.Y., Woo, H.J., Choi, Y.H., Son, J.S., Kim, K.H., Kim, Y.S., et al. 2016a. Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity. Clin. Microbiol. Infect. 22, 880–886.
53. Kim, M.N., Ko, Y.J., Seong, M.W., Kim, J.S., Shin, B.M., and Sung, H. 2016b. Analytical and clinical validation of six commercial Middle East respiratory syndrome coronavirus RNA Detection kits based on real-time reverse-transcription PCR. Ann. Lab. Med. 36, 450–456.
54. Kim, S.Y., Park, S.J., Cho, S.Y., Cha, R.H., Jee, H.G., Kim, G., Shin, H.S., Kim, Y., Jung, Y.M., Yang, J.S., et al. 2016c. Viral RNA in blood as indicator of severe outcome in Middle East respiratory syndrome coronavirus infection. Emerg. Infect. Dis. 22, 1813–1816.
55. Lau, S.K., Lau, C.C., Chan, K.H., Li, C.P., Chen, H., Jin, D.Y., Chan, J.F., Woo, P.C., and Yuen, K.Y. 2013a. Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment. J. Gen. Virol. 94, 2679–2690.
56. Lau, S.K., Li, K.S., Tsang, A.K., Lam, C.S., Ahmed, S., Chen, H., Chan, K.H., Woo, P.C., and Yuen, K.Y. 2013b. Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus. J. Virol. 87, 8638–8650.
57. Lau, S.K., Wernery, R., Wong, E.Y., Joseph, S., Tsang, A.K., Patteril, N.A., Elizabeth, S.K., Chan, K.H., Muhammed, R., Kinne, J., et al. 2016. Polyphyletic origin of MERS coronaviruses and isolation of a novel clade A strain from dromedary camels in the United Arab Emirates. Emerg. Microbes Infect. 5, e128.
58. Lu, L., Liu, Q., Zhu, Y., Chan, K.H., Qin, L., Li, Y., Wang, Q., Chan, J.F., Du, L., Yu, F., et al. 2014a. Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. Nat. Commun. 5, 3067.
59. Lu, X., Whitaker, B., Sakthivel, S.K., Kamili, S., Rose, L.E., Lowe, L., Mohareb, E., Elassal, E.M., Al-sanouri, T., Haddadin, A., et al. 2014b. Real-time reverse transcription-PCR assay panel for Middle East respiratory syndrome coronavirus. J. Clin. Microbiol. 52, 67–75.
60. Memish, Z.A., Al-Tawfiq, J.A., Assiri, A., AlRabiah, F.A., Al Hajjar, S., Albarrak, A., Flemban, H., Alhakeem, R.F., Makhdoom, H.Q., Alsubaie, S., et al. 2014a. Middle East respiratory syndrome coronavirus disease in children. Pediatr. Infect. Dis. J. 33, 904–906.
61. Memish, Z.A., Al-Tawfiq, J.A., Makhdoom, H.Q., Assiri, A., Alhakeem, R.F., Albarrak, A., Alsubaie, S., Al-Rabeeah, A.A., Hajomar, W.H., Hussain, R., et al. 2014b. Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome. J. Infect. Dis. 210, 1590–1594.
62. Memish, Z.A., Zumla, A.I., and Assiri, A. 2013. Middle East respiratory syndrome coronavirus infections in health care workers. N. Engl. J. Med. 369, 884–886.
63. Meyer, B., Drosten, C., and Muller, M.A. 2014a. Serological assays for emerging coronaviruses: challenges and pitfalls. Virus Res. 194, 175–183.
64. Meyer, B., Muller, M.A., Corman, V.M., Reusken, C.B., Ritz, D., Godeke, G.J., Lattwein, E., Kallies, S., Siemens, A., van Beek, J., et al. 2014b. Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013. Emerg. Infect. Dis. 20, 552–559.
65. Muller, M.A., Meyer, B., Corman, V.M., Al-Masri, M., Turkestani, A., Ritz, D., Sieberg, A., Aldabbagh, S., Bosch, B.J., Lattwein, E., et al. 2015. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study. Lancet Infect. Dis. 15, 559–564.
66. Muller, M.A., Raj, V.S., Muth, D., Meyer, B., Kallies, S., Smits, S.L., Wollny, R., Bestebroer, T.M., Specht, S., Suliman, T., et al. 2012. Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines. MBio 3, pii: e00515-12.
67. Munster, V.J., de Wit, E., and Feldmann, H. 2013. Pneumonia from human coronavirus in a macaque model. N. Engl. J. Med. 368, 1560–1562.
68. Muth, D., Corman, V.M., Meyer, B., Assiri, A., Al-Masri, M., Farah, M., Steinhagen, K., Lattwein, E., Al-Tawfiq, J.A., Albarrak, A., et al. 2015. Infectious Middle East respiratory syndrome coronavirus excretion and serotype variability based on live virus isolates from patients in Saudi Arabia. J. Clin. Microbiol. 53, 2951–2955.
69. Oboho, I.K., Tomczyk, S.M., Al-Asmari, A.M., Banjar, A.A., Al- Mugti, H., Aloraini, M.S., Alkhaldi, K.Z., Almohammadi, E.L., Alraddadi, B.M., Gerber, S.I., et al. 2015. 2014 MERS-CoV outbreak in Jeddah—a link to health care facilities. N. Engl. J. Med. 372, 846–854.
70. Oh, M.D., Park, W.B., Choe, P.G., Choi, S.J., Kim, J.I., Chae, J., Park, S.S., Kim, E.C., Oh, H.S., Kim, E.J., et al. 2016. Viral load kinetics of MERS coronavirus infection. N. Engl. J. Med. 375, 1303–1305.
71. Omrani, A.S., Matin, M.A., Haddad, Q., Al-Nakhli, D., Memish, Z.A., and Albarrak, A.M. 2013. A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case. Int. J. Infect. Dis. 17, e668–672.
72. Palm, D., Pereyaslov D., Vaz, J., Broberg, E., Zeller, H., Gross, D., Brown, C.S., Struelens, M.J., Joint ECDC-WHO Regional Office for Europe Novel Coronavirus Laboratory Survey participants, ECDC National Microbiology Focal Points, et al. 2012. Laboratory capability for molecular detection and confirmation of novel coronavirus in Europe, November 2012. Euro Surveill. 17, pii: 20335.
73. Park, S.W., Perera, R.A., Choe, P.G., Lau, E.H., Choi, S.J., Chun, J.Y., Oh, H.S., Song, K.H., Bang, J.H., Kim, E.S., et al. 2015a. Comparison of serological assays in human Middle East respiratory syndrome (MERS)-coronavirus infection. Euro Surveill. 20, pii= 30042.
74. Park, W.B., Perera, R.A., Choe, P.G., Lau, E.H., Choi, S.J., Chun, J.Y., Oh, H.S., Song, K.H., Bang, J.H., Kim, E.S., et al. 2015b. Kinetics of serologic responses to MERS Coronavirus infection in humans, South Korea. Emerg. Infect. Dis. 21, 2186–2189.
75. Pas, S.D., Patel, P., Reusken, C., Domingo, C., Corman, V.M., Drosten, C., Dijkman, R., Thiel, V., Nowotny, N., Koopmans, M.P., et al. 2015. First international external quality assessment of molecular diagnostics for Mers-CoV. J. Clin. Virol. 69, 81–85.
76. Payne, D.C., Iblan, I., Rha, B., Alqasrawi, S., Haddadin, A., Al Nsour, M., Alsanouri, T., Ali, S.S., Harcourt, J., Miao, C., et al. 2016. Persistence of antibodies against Middle East respiratory syndrome coronavirus. Emerg. Infect. Dis. 22, 1824–1826.
77. Perera, R.A., Wang, P., Gomaa, M.R., El-Shesheny, R., Kandeil, A., Bagato, O., Siu, L.Y., Shehata, M.M., Kayed, A.S., Moatasim, Y., et al. 2013. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill. 18, pii=20574.
78. Poissy, J., Goffard, A., Parmentier-Decrucq, E., Favory, R., Kauv, M., Kipnis, E., Mathieu, D., van der Werf, S., Guery, B., and M. E.-C. B. Group. 2014. Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases. J. Clin. Virol. 61, 275–278.
79. Reusken, C.B., Haagmans, B.L., Muller, M.A., Gutierrez, C., Godeke, G.J., Meyer, B., Muth, D., Raj, V.S., Smits- de Vries, L., Corman, V.M., et al. 2013a. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect. Dis. 13, 859–866.
80. Reusken, C., Mou, H., Godeke, G.J., van der Hoek, L., Meyer, B., Muller, M.A., Haagmans, B., de Sousa, R., Schuurman, N., Dittmer, U., et al. 2013b Specific serology for emerging human coronaviruses by protein microarray. Euro Surveill. 18, pii=20441.
81. Scheuplein, V.A., Seifried, J., Malczyk, A.H., Miller, L., Hocker, L., Vergara-Alert, J., Dolnik, O., Zielecki, F., Becker, B., Spreitzer, I., et al. 2015. High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus. J. Virol. 89, 3859–3869.
82. Seong, M.W., Lee, S.J., Cho, S.I., Ko, K., Kim, M.N., Sung, H., Kim, J.S., Ahn, J.S., Yu, B.S., Kim, T.S., et al. 2016. External quality assessment of MERS-CoV molecular diagnostics during the 2015 Korean Outbreak. Ann. Lab. Med. 36, 230–234.
83. Shirato, K., Yano, T., Senba, S., Akachi, S., Kobayashi, T., Nishinaka, T., Notomi, T., and Matsuyama, S. 2014. Detection of Middle East respiratory syndrome coronavirus using reverse transcription loop-mediated isothermal amplification (RT-LAMP). Virol. J. 11, 139.
84. Song, D., Ha, G., Serhan, W., Eltahir, Y., Yusof, M., Hashem, F., Elsayed, E., Marzoug, B., Abdelazim, A., and Al Muhairi, S. 2015. Development and validation of a rapid immunochromatographic assay for detection of Middle East respiratory syndrome coronavirus antigen in dromedary camels. J. Clin. Microbiol. 53, 1178–1182.
85. Sridhar, S., To, K.K., Chan, J.F., Lau, S.K., Woo, P.C., and Yuen, K.Y. 2015. A systematic approach to novel virus discovery in emerging infectious disease outbreaks. J. Mol. Diagn. 17, 230–241.
86. Sung, H., Yong, D., Ki, C.S., Kim, J.S., Seong, M.W., Lee, H., and Kim, M.N. 2016. Comparative evaluation of three homogenization methods for isolating Middle East respiratory syndrome coronavirus nucleic acids from sputum samples for real-time reverse transcription PCR. Ann. Lab. Med. 36, 457–462.
87. Tang, X.C., Agnihothram, S.S., Jiao, Y., Stanhope, J., Graham, R.L., Peterson, E.C., Avnir, Y., Tallarico, A.S., Sheehan, J., Zhu, Q., et al. 2014. Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution. Proc. Natl. Acad. Sci. USA 111, e2018–2026.
88. To, K.K., Chan, J.F., Chen, H., Li, L., and Yuen, K.Y. 2013. The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities. Lancet Infect. Dis. 13, 809–821.
89. To, K.K., Chan, J.F., Tsang, A.K., Cheng, V.C., and Yuen, K.Y. 2015. Ebola virus disease: a highly fatal infectious disease reemerging in West Africa. Microbes Infect. 17, 84–97.
90. To, K.K., Tsang, A.K., Chan, J.F., Cheng, V.C., Chen, H., and Yuen, K.Y. 2014. Emergence in China of human disease due to avian influenza A(H10N8)–cause for concern? J. Infect. 68, 205–215.
91. Tynell, J., Westenius, V., Ronkko, E., Munster, V.J., Melen, K., Osterlund, P., and Julkunen, I. 2016. Middle East respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocyte-derived macrophages and dendritic cells. J. Gen. Virol. 97, 344–355.
92. Uyeki, T.M., Erlandson, K.J., Korch, G., O’Hara, M., Wathen, M., Hu-Primmer, J., Hojvat, S., Stemmy, E.J., and Donabedian, A. 2016. Development of medical countermeasures to Middle East respiratory syndrome coronavirus. Emerg. Infect. Dis. 22, DOI: 10.3201/eid2207.160022.
93. Wang, Q., Qi, J., Yuan, Y., Xuan, Y., Han, P., Wan, Y., Ji, W., Li, Y., Wu, Y., Wang, J., et al. 2014. Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26. Cell Host Microbe 16, 328–337.
94. Wang, W., Wang, H., Deng, Y., Song, T., Lan, J., Wu, G., Ke, C., and Tan, W. 2016a. Characterization of anti-MERS-CoV antibodies against various recombinant structural antigens of MERS-CoV in an imported case in China. Emerg. Microbes Infect. 5, e113.
95. Wang, W.L., Wang, H.J., Deng, Y., Song, T., Lan, J.M., Wu, G.Z., Ke, C.W., and Tan, W.J. 2016b. Serological study of an imported case of Middle East respiratory syndrome and his close contacts in China, 2015. Biomed. Environ. Sci. 29, 219–223.
96. Wernery, U., El Rasoul, I.H., Wong, E.Y., Joseph, M., Chen, Y., Jose, S., Tsang, A.K., Patteril, N.A., Chen, H., Elizabeth, S.K., et al. 2015. A phylogenetically distinct Middle East respiratory syndrome coronavirus detected in a dromedary calf from a closed dairy herd in Dubai with rising seroprevalence with age. Emerg. Microbes Infect. 4, e74.
97. Woo, P.C., Lau, S.K., Li, K.S., Tsang, A.K., and Yuen, K.Y. 2012. Genetic relatedness of the novel human group C betacoronavirus to Tylonycteris bat coronavirus HKU4 and Pipistrellus bat coronavirus HKU5. Emerg. Microbes Infect. 1, e35.
98. Woo, P.C., Lau, S.K., Wong, B.H., Chan, K.H., Chu, C.M., Tsoi, H.W., Huang, Y., Peiris, J.S., and Yuen, K.Y. 2004. Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus. Clin. Diagn. Lab. Immunol. 11, 665–668.
99. Woo, P.C., Lau, S.K., Wong, B.H., Tsoi, H.W., Fung, A.M., Kao, R.Y., Chan, K.H., Peiris, J.S., and Yuen, K.Y. 2005. Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia. J. Clin. Microbiol. 43, 3054–3058.
100. Yamaoka, Y., Matsuyama, S., Fukushi, S., Matsunaga, S., Matsushima, Y., Kuroyama, H., Kimura, H., Takeda, M., Chimuro, T., and Ryo, A. 2016. Development of monoclonal antibody and diagnostic test for Middle East respiratory syndrome coronavirus using cell-free synthesized nucleocapsid antigen. Front. Microbiol. 7, 509.
101. Yao, Y., Bao, L., Deng, W., Xu, L., Li, F., Lv, Q., Yu, P., Chen, T., Xu, Y., Zhu, H., et al. 2014. An animal model of MERS produced by infection of rhesus macaques with MERS coronavirus. J. Infect. Dis. 209, 236–242.
102. Yaren, O., Glushakova, L.G., Bradley, K.M., Hoshika, S., and Benner, S.A. 2016. Standard and AEGIS nicking molecular beacons detect amplicons from the Middle East respiratory syndrome coronavirus. J. Virol. Methods 236, 54–61.
103. Yeung, M.L., Yao, Y., Jia, L., Chan, J.F., Chan, K.H., Cheung, K.F., Chen, H., Poon, V.K., Tsang, A.K., To, K.K., et al. 2016. MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2. Nat. Microbiol. 1, 16004.
104. Ying, T., Du, L., Ju, T.W., Prabakaran, P., Lau, C.C., Lu, L., Liu, Q., Wang, L., Feng, Y., Wang, Y., et al. 2014. Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies. J. Virol. 88, 7796–7805.
105. Zaki, A.M., van Boheemen, S., Bestebroer, T.M., Osterhaus, A.D., and Fouchier, R.A. 2012. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 367, 1814–1820.
106. Zhang, L., Hao, M., Zhang, K., Zhang, R., Lin, G., Jia, T., Zhang, D., Chang, L., Xie, J., and Li, J. 2016. External quality assessment for the molecular detection of MERS-CoV in China. J. Clin. Virol. 75, 5–9.
107. Zhao, J., Li, K., Wohlford-Lenane, C., Agnihothram, S.S., Fett, C., Zhao, J., Gale, M.J., Baric, R.S.Jr., Enjuanes, L., Gallagher, T., et al. 2014. Rapid generation of a mouse model for Middle East respiratory syndrome. Proc. Natl. Acad. Sci. USA 111, 4970–4975.
108. Zhou, J., Chu, H., Chan, J.F., and Yuen, K.Y. 2015. Middle East respiratory syndrome coronavirus infection: virus-host cell interactions and implications on pathogenesis. Virol. J. 12, 218.
109. Zhou, J., Chu, H., Li, C., Wong, B.H., Cheng, Z.S., Poon, V.K., Sun, T., Lau, C.C., Wong, K.K., Chan, J.Y., et al. 2014. Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis. J. Infect. Dis. 209, 1331–1342.
110. Zumla, A., Chan, J.F., Azhar, E.I., Hui, D.S., and Yuen, K.Y. 2016. Coronaviruses–drug discovery and therapeutic options. Nat. Rev. Drug. Discov. 15, 327–347.